Discontinuation report PROZAC CAPSULES 10MG
Report ID | 238851 |
Drug Identification Number | 02018985 |
Brand name | PROZAC CAPSULES 10MG |
Common or Proper name | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUOXETINE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | Bottle containing 100 capsules |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-09-25 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No remaining supply |
Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-09-27 | French | Compare |
v2 | 2024-09-27 | English | Compare |
v1 | 2024-09-27 | English | Compare |
Showing 1 to 3 of 3